CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Earnings & Estimates
NASDAQ:CNTB - US2075231017 - ADR
2.11 USD
+0.05 (+2.43%)
2.15 USD
+0.04 (+1.9%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 26.033M | -100.00% | 73.957M | 127.58M 72.51% | 23.824M -81.33% | 64.646M 171.35% | 86.446M 33.72% | 216.03M 149.90% | 282.42M 30.73% | |||
| EBITDA YoY % growth | -777.18M -24.54% | -71.202M 90.84% | -19.792M 72.20% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -784.12M -24.83% | -71.931M 90.83% | -20.452M 71.57% | -394.546M -1,829.13% | -357.242M 9.46% | -322.121M 9.83% | -53.771M 83.31% | -29.589M 44.97% | 10.203M 134.48% | 55.811M 447.01% | 107.64M 92.87% | |
| Operating Margin | N/A | N/A | -78.56% | N/A | -483.04% | -252.49% | -225.70% | -45.77% | 11.80% | 25.83% | 38.11% | |
| EPS YoY % growth | N/A 40.75% | N/A 59.72% | N/A 73.94% | -6.74 -328.29% | -5.35 20.62% | -4.32 19.27% | -0.62 85.60% | -0.32 49.18% | -0.18 43.55% | 0.48 368.57% | 0.94 95.74% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -1.79 | -1.94 |
| Revenue Q2Q % growth | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -104.309M | -111.994M -447.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.23 | -0.92 | 0.69 | 74.98% |
| Q1 2025 Q2Q % growth | -0.19 | -1.92 | 1.73 | 90.13% |
| Q4 2023 Q2Q % growth | 13.34% | -6.92 | % | |
| Q3 2023 Q2Q % growth | -13.13% | -4.13 | % | |
| Q2 2023 Q2Q % growth | -3.90 48.81% | -7.06 | 3.16 | 44.80% |
| Q1 2023 Q2Q % growth | -7.34% | -3.58 | % | |
| Q4 2022 Q2Q % growth | -77.79% | -7.98 | % | |
| Q3 2022 Q2Q % growth | -43.66% | -3.65 | % | |
| Q2 2022 Q2Q % growth | -7.62 -217.14% | -5.08 | -2.54 | -50.08% |
| Q1 2022 Q2Q % growth | 57.51% | -3.34 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 48K -99.80% | 48K | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -5.6% | 6.73% |
| Revenue | N/A | N/A | N/A | N/A |